Ohkuma, Toshiaki
Iwase, Masanori
Fujii, Hiroki
Ide, Hitoshi
Kaizu, Shinako
Jodai, Tamaki
Kikuchi, Yohei
Idewaki, Yasuhiro
Sumi, Akiko
Nakamura, Udai
Kitazono, Takanari
Funding for this research was provided by:
the Japan Society for the Promotion of Science KAKENHI (23249037, 23659353, 16K00861)
a grant from the Japan Diabetes Foundation
the Japan Heart Foundation and Astellas/Pfizer Grant for Research on Atherosclerosis Update
Article History
Received: 3 October 2016
Accepted: 31 January 2017
First Online: 17 February 2017
Compliance with ethical standards
:
: Honoraria for lectures: Takanari Kitazono (Daiichi-Sankyo Company, Limited, Bayer Yakuhin, Limited). Total clinical research grants: Takanari Kitazono (Mitsubishi Tanabe Pharma Corporation, Daiichi-Sankyo Company, Limited, Astellas Pharma Incorporated, Takeda Pharmaceutical Company, Limited, Eisai Company, Limited, Chugai Pharmaceutical Company, Limited, Merck Sharp and Dohme, Sanofi K.K.).
: All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. Informed consent was obtained from all patients for being included in the study.